The Mission of Sanofi’s Medical Science Liaison (MSL) is to be the trusted scientific partners in the field for external experts and decision-makers engaging in mutual scientific exchanges to accelerate data dissemination. Sanofi’s MSLs enhance the understanding of the scientific and medical value of our products in the therapeutic area and gather new insights by bringing cutting edge scientific exchange that accelerates medical innovation

1. Key accountabilities

1-1. Engages external stakeholders on medical and scientific information exchange for rare diseases

Uses strong knowledge of rare diseases and disease management protocols, healthcare environment and competitors to articulate the medical and scientific value of our products with external experts.

Establishes robust, long-term peer relationships with Key Opinion Leaders and other stakeholder partners.

Actively engages with appropriate stakeholders on medical, clinical, epidemiologic, and scientific topics to advance their understanding of the disease by sharing information and answering questions based on approved material within regulatory guidelines.

Uses defined systems to maps, identify, profile, and prioritizes stakeholders in line with the therapeutic area medical plan and looks for opportunities to collaborate and build a value-based partnership addressing the HCPs therapeutic goals.

Organizes educational meetings or local scientific advisory boards when requested.

Responds to unsolicited request for medical information associated with supported products and disease state area.

1-2. Gathers data and generates insights from stakeholder interactions and provides feedback to the organization

Recognize and collect feedback/reactions from multiple data sources and various stakeholders.

Record/report insights and information appropriately, using available mechanisms and tools (OneCRM, Teams, etc.).

Develop key insights that deepen our understanding of the market’s needs and opinions of external stakeholders and therefore contribute to enhancement of Sanofi’s scientific messages, plans, strategy, systems, and product development.

Maintain awareness of and assesses emerging evidence in disease area to educate and enhance discussions with key stakeholders.

1-3. Collaborates effectively with internal stakeholders

Distribute relevant scientific and medical information and key external insights to internal stakeholders as directed.

Collaborate, as directed, with Clinical Study Unit, Commercial Operations, Regulatory, Business Development, etc. to facilitate diligence reviews, medical and safety evaluation, product positioning, lifecycle planning, and compliance needs.

1-4. Supports evidence-generation activities by aiding in data acquisition and identifying opportunities for further data collection

Identifies data collection opportunities during stakeholder interactions and reports these using approved processes.

Maintains awareness of clinical trial activity within territory and suggests clinical trials sites as requested.

Responds to unsolicited requests regarding interest in investigator sponsored studies (ISS), and supports ISS submissions through appropriate internal processes.

 

2. Requirements

2-1. Education / experience

Advanced degree in a technical, scientific or medical field (MD, PhD, Pharm D,) preferred, or other relevant life sciences degree with healthcare specialty required.

Areas of specialization related to rare diseases preferred.

Prior experiences as an MSL or other field medical roles required.

 

2-1. Skills / knowledge

Scientific expertise - stays abreast of data, treatment trends, and new information in the profession and ability to articulate rare disease knowledge and translate expert feedback into appropriate insights.

Professional communication skills to cultivate strong working relationships with internal and external colleagues.

Deep understanding and knowledge of local regulations and codes of practice for pharmaceutical industry.

Knowledge of relevant healthcare systems, the evolving medical landscape, regulatory and payer environment, public health and industry trends.

Proficiency in digital tools.

Japanese: native level

Working knowledge of English as a second language.

【Selling Point】

We have a robust pipeline that includes not only in-house development products and label expansions, but also several planned in-licensing opportunities.As lysosomal diseases are systemic disorders, this role offers the opportunity to gain experience across a wide range of disease areas.Sanofi, with its roots in Genzyme—a pioneer in rare diseases—has over 40 years of history and leadership in this field.

At Sanofi, we provide equal opportunities to all regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity. 

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!

Pursue progress, discover extraordinary

Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.

At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!